How Close are We to a COVID-19 Treatment?
Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...
5 years agoHow Close are We to a COVID-19 Treatment?
Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...
5 years ago
Weekly News Round-up – 20/3/20
For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...
5 years agoWeekly News Round-up – 20/3/20
For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...
5 years ago
Weekly News Round-Up – 6/3/20
Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...
5 years agoWeekly News Round-Up – 6/3/20
Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...
5 years ago
R&D: The Impact of AI in 2020
Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...
5 years agoR&D: The Impact of AI in 2020
Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...
5 years ago
Weekly News Round-up – 28/2/20
Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...
5 years agoWeekly News Round-up – 28/2/20
Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...
5 years ago
Weekly News Round-up – 21/2/20
Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...
5 years agoWeekly News Round-up – 21/2/20
Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...
5 years ago
The Changing Role of the Blockbuster Drug
There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...
5 years agoThe Changing Role of the Blockbuster Drug
There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...
5 years ago
Weekly News Round-up – 31/1/20
With the Chinese Coronavirus dominating the news this week, headlines were a diverse affair: Novartis has backed out of a generic program copying Advair, with the company citing that they could no longer see a way to launch in the...
5 years agoWeekly News Round-up – 31/1/20
With the Chinese Coronavirus dominating the news this week, headlines were a diverse affair: Novartis has backed out of a generic program copying Advair, with the company citing that they could no longer see a way to launch in the...
5 years ago
How Can We Speed up Vaccine R&D?
With the rapid spread of the coronavirus 2019-nCoV through China and now globally, governments and organisations have implemented a range of preventative measures. Chinese provinces including Beijing and Shanghai have shut down long-distance bus services and entirely closed off some...
5 years agoHow Can We Speed up Vaccine R&D?
With the rapid spread of the coronavirus 2019-nCoV through China and now globally, governments and organisations have implemented a range of preventative measures. Chinese provinces including Beijing and Shanghai have shut down long-distance bus services and entirely closed off some...
5 years ago
Antibiotic Resistance: Is Pharma Doing Enough?
Developed resistances to certain antibiotics have occurred since their creation in the 1940s. Scientists found the first case of resistance just four years after antibiotics entered mass production. Only recently, however, has the issue taken a critical turn. Resistant strains of...
5 years agoAntibiotic Resistance: Is Pharma Doing Enough?
Developed resistances to certain antibiotics have occurred since their creation in the 1940s. Scientists found the first case of resistance just four years after antibiotics entered mass production. Only recently, however, has the issue taken a critical turn. Resistant strains of...
5 years ago